Skip to main content
Equibles

Amet

Analyst

H.C. Wainwright

Equibles does not estimate personal net worth.

About Amet

Amet is recorded as Analyst at H.C. Wainwright. Amet has spoken on 1 earnings call across 1 company, most recently for Legend Biotech Corp on November 10, 2026. The companies whose calls Amet spoke on are classified in the Healthcare sector.

Amet on recent calls

“So, two for me, one on CARVICTE and one on 2501. So, for CARVICTE, within the community, are you seeing the incremental patients coming from physicians making their first CARVICTE referral or from existing referrers sending more eligible patients?”
Analyst — H.C. Wainwright, Legend Biotech Reports Third Quarter 2026 Financial Results ·

Affiliation history

  • H.C. Wainwright

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity